Ronald N. Marcus

9.1k total citations
87 papers, 6.5k citations indexed

About

Ronald N. Marcus is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Ronald N. Marcus has authored 87 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Psychiatry and Mental health, 23 papers in Pharmacology and 21 papers in Clinical Psychology. Recurrent topics in Ronald N. Marcus's work include Schizophrenia research and treatment (50 papers), Bipolar Disorder and Treatment (33 papers) and Treatment of Major Depression (23 papers). Ronald N. Marcus is often cited by papers focused on Schizophrenia research and treatment (50 papers), Bipolar Disorder and Treatment (33 papers) and Treatment of Major Depression (23 papers). Ronald N. Marcus collaborates with scholars based in United States, Germany and Belgium. Ronald N. Marcus's co-authors include Robert D. McQuade, William H. Carson, George Manos, Randall Owen, Robert Berman, Raymond Sanchez, René Swanink, Elyse Stock, Mirza W. Ali and Anutosh Ranjan Saha and has published in prestigious journals such as American Journal of Psychiatry, PEDIATRICS and Biological Psychiatry.

In The Last Decade

Ronald N. Marcus

85 papers receiving 6.2k citations

Peers

Countries citing papers authored by Ronald N. Marcus

Since Specialization

Citations

This map shows the geographic impact of Ronald N. Marcus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald N. Marcus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald N. Marcus more than expected).

Fields of papers citing papers by Ronald N. Marcus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald N. Marcus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald N. Marcus. The network helps show where Ronald N. Marcus may publish in the future.

Co-authorship network of co-authors of Ronald N. Marcus

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald N. Marcus. A scholar is included among the top collaborators of Ronald N. Marcus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald N. Marcus. Ronald N. Marcus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia 2025 ·The Journal of Clinical Psychiatry ·Inder Kaul, Amy Claxton, Sharon Sawchak, Colin Sauder, Stephen K. Brannan, (unknown), (unknown), (unknown), David T. Brown, Andrew J. Cutler, Ronald N. Marcus	4
2	Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy 2014 ·International Journal of Clinical Practice ·Dympna Casey, Kimberly K. Laubmeier, James M. Eudicone, Ronald N. Marcus, Robert Berman, Ziaur Rahman, John J. Sheehan	4
3	A Randomized Controlled Trial Investigating the Safety and Efficacy of Aripiprazole in the Long-Term Maintenance Treatment of Pediatric Patients With Irritability Associated With Autistic Disorder 2014 ·The Journal of Clinical Psychiatry ·Robert L. Findling, Raymond Mankoski, (unknown), (unknown), (unknown), Robert D. McQuade, James M. Eudicone, Joan Amatniek, Ronald N. Marcus, John J. Sheehan	67
4	Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy 2014 ·CNS Spectrums ·J. Craig Nelson, Zia Ur Rahman, Kimberly K. Laubmeier, James M. Eudicone, Robert D. McQuade, Robert Berman, Ronald N. Marcus, Ross A. Baker, John J. Sheehan	11
5	BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial 2013 ·Cephalalgia ·Ronald N. Marcus, Peter J. Goadsby, David W. Dodick, David Stock, George Manos, Tanya Fischer	225
6	Aripiprazole Treatment of Irritability Associated with Autistic Disorder and the Relationship Between Prior Antipsychotic Exposure, Adverse Events, and Weight Change 2013 ·Journal of Child and Adolescent Psychopharmacology ·Raymond Mankoski, (unknown), George Manos, (unknown), Robert D. McQuade, Robert A. Forbes, Ronald N. Marcus	25
7	Aripiprazole in the Treatment of Irritability in Pediatric Patients (Aged 6–17 Years) with Autistic Disorder: Results from a 52-Week, Open-Label Study 2011 ·Journal of Child and Adolescent Psychopharmacology ·Ronald N. Marcus, Randall Owen, George Manos, Raymond Mankoski, Lisa Kamen, Robert D. McQuade, William H. Carson, Patricia K. Corey‐Lisle, Michael G. Aman	57
8	Safety and Tolerability of Aripiprazole for Irritability in Pediatric Patients With Autistic Disorder 2011 ·The Journal of Clinical Psychiatry ·Ronald N. Marcus, Randall Owen, George Manos, Raymond Mankoski, Lisa Kamen, Robert D. McQuade, William H. Carson, Robert L. Findling	63
9	Line-Item Analysis of the Aberrant Behavior Checklist: Results from Two Studies of Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder 2010 ·Journal of Child and Adolescent Psychopharmacology ·Michael G. Aman, (unknown), George Manos, (unknown), Ronald N. Marcus, Randall Owen, Raymond Mankoski	43
10	A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007) 2010 ·European Neuropsychopharmacology ·(unknown), Eduard Vieta, Linda Rollin, Ronald N. Marcus, William H. Carson, Robert D. McQuade	36
11	Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia 2010 ·Schizophrenia Research ·John P. Docherty, Ross A. Baker, James M. Eudicone, (unknown), Ronald N. Marcus, Robert D. McQuade, Raymond Mankoski	16
12	A Multicenter, Randomized, Double-Blind Study of the Effects of Aripiprazole in Overweight Subjects With Schizophrenia or Schizoaffective Disorder Switched From Olanzapine 2008 ·The Journal of Clinical Psychiatry ·John W. Newcomer, (unknown), Ronald N. Marcus, Christopher D. Breder, Robert Berman, W. Kerselaers, Gilbert L’Italien, Marleen Nys, William H. Carson, Robert D. McQuade	96
13	The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913) 2008 ·BMC Psychiatry ·Linda Hanssens, Gilbert L’Italien, Jean‐Yves Loze, Ronald N. Marcus, Miranda Pans, W. Kerselaers	65
14	Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study 2008 ·Schizophrenia Research ·Matthew Byerly, Ronald N. Marcus, Quynh-Van Tran, James M. Eudicone, Richard Whitehead, Ross A. Baker	71
15	Management of Acute Agitation in Patients With Bipolar Disorder 2007 ·Journal of Clinical Psychopharmacology ·Dan Zimbroff, Ronald N. Marcus, George Manos, Elyse Stock, Robert D. McQuade, Philippe Auby, Dan A. Oren	70
16	Antimanic Response to Aripiprazole in Bipolar I Disorder Patients Is Independent of the Agitation Level at Baseline 2007 ·The Journal of Clinical Psychiatry ·Roy H. Perlis, B. D. Gaulin, Rolando Gutierrez-Esteinou, Robert D. McQuade, (unknown), Joseph Pultz, Raymond Sanchez, Ronald N. Marcus, David Crandall	19
17	Aripiprazole Effects in Patients With Acute Schizophrenia Experiencing Higher or Lower Agitation 2007 ·The Journal of Clinical Psychiatry ·Stephen R. Marder, (unknown), (unknown), Joseph Pultz, (unknown), Ronald N. Marcus, Rolando Gutierrez-Esteinou, David Crandall	20
18	Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol 2006 ·Psychopharmacology ·(unknown), Richard C. Josiassen, Ronald N. Marcus, Dan A. Oren, George Manos, Elyse Stock, William H. Carson, Taro Iwamoto	80
19	A Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Aripiprazole in Patients With Acute Bipolar Mania 2003 ·American Journal of Psychiatry ·Paul E. Keck, Ronald N. Marcus, Stavros Tourkodimitris, Mirza W. Ali, Amy Liebeskind, Anutosh Ranjan Saha, Г. Ингенито, (unknown)	341
20	Inpatient Care of the Substance-Abusing Patient With a Concomitant Eating Disorder 1990 ·Psychiatric Services ·Ronald N. Marcus, Jack Katz	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact